Division of Community HIV/AIDS Programs: RWC 2022 Business Day Meeting
HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.
Resource (Conference Presentation) updated 09/14/2023
HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 01/10/2024
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
BLOC partners share how the BLOC program and curriculum were developed, implemented, and evaluated, including adaptations for key populations.
Resource (Conference Presentation) updated 09/14/2023
This 12-week pilot program focused on addressing the needs of long-term survivors.
Resource (Conference Presentation) updated 09/14/2023
Introduction of the full grant life cycle of a RWHAP Part C Early Intervention Services award.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 01/09/2024
Resource from the RWHAP Best Practices Compilation updated on 03/23/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource updated 04/16/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
RWHAP Technical Assistance Provider updated on 02/27/2024
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
After language-specific outreach on getting a COVID-19 vaccination, project saw a high rate of vaccine uptake in Spanish-speaking patients (81%) compared to English-speaking patients (4%).
Resource (Conference Presentation) updated 09/14/2023